Clinical Trial Update: A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP [Phase 2]

View source ↗

Summary

Phase 2 open multicenter trial evaluating eltrombopag combined with diacerein in eltrombopag-inefficient or relapsed thrombocytopenia (ITP) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Diacerein (Diacerein)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: Shandong University | Conditions: Thrombocytopenia | Phase 2 | Status: COMPLETED